Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Lung Transplants From Hepatitis C-Positive Donors (HCV)

Condition:   Lung Diseases Intervention:   Drug: Zepatier Sponsors:   University of Pennsylvania;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials